INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 16, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 400,000 | -- | 400,000 |
| Jan 05, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 333,000 | -- | 70,000 |
| Nov 18, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 325,986 | -- | 325,986 |
| Nov 18, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 325,986 | -- | -- |
| Jul 24, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 299,134 | -- | 24,643 |
| Jul 24, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 299,134 | -- | 385,954 |
| Jan 05, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 263,000 | -- | -- |
| Dec 18, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 257,850 | $386.90 | 422,762 |
| Dec 14, 2010 |
Director, EVP CSO & Pres Regn Res Labs
|
Director, EVP CSO & Pres Regn Res Labs | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 870,375 |
| Dec 19, 2017 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 242,150 | -- | 847 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.